Chylomicron-responsive Tregs in EED

EED 中的乳糜微粒反应性 Tregs

基本信息

项目摘要

Abstract. A quarter of the world’s children experience chronic malnutrition coupled with a lack of access to clean drinking water. This combination results in Environmental Enteric Dysfunction (EED), a disease where intestinal malabsorption exacerbates malnutrition, leading to increased cognitive deficiencies, stunted growth and mortality. The intestine of EED patients is characterized by inflammation and flattened villi in the small intestine that negatively affect absorptive capacity. Our groups have recently identified a pool of protective Tregs in the small intestine that respond specifically to dietary lipid absorption, to the presence or absence of chylomicrons secreted in response to dietary lipids, and to EED. We hypothesize that lipid absorption and chylomicron secretion is reduced in the EED intestine, that EED-chylomicrons deliver less dietary triglyceride to mesenteric LN Tregs, and that replenishing calories by bypassing the chylomicron pathway (with a medium-chain- triglycerides) will restore calories without blocking the effect EED-chylomicrons that will travel by the lymph to stimulate protective intestinal Tregs.
抽象。 世界上有四分之一的儿童长期营养不良,而且无法获得清洁饮用水。 水这种组合导致环境性肠功能障碍(EED),一种肠道疾病, 吸收不良加剧营养不良,导致认知缺陷增加,生长发育迟缓, mortality. EED患者的肠道特征是小肠中的炎症和扁平绒毛 这对吸收能力产生了负面影响。我们的研究小组最近发现, 小肠对膳食脂质吸收、乳糜微粒的存在或不存在有特异性反应 对饮食脂质和EED的反应。我们假设脂质吸收和乳糜微粒 EED肠道中的分泌减少,EED-乳糜微粒向肠系膜递送较少的膳食甘油三酯 LN Tlymphocyte,以及通过绕过乳糜微粒途径(具有中链- 甘油三酯)将恢复热量,而不会阻止EED-乳糜微粒的作用,这些乳糜微粒将通过淋巴, 刺激保护性肠肌张力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy Wesley Hand其他文献

Timothy Wesley Hand的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy Wesley Hand', 18)}}的其他基金

Investigating the tissue location and protective function of oral vaccine-specific tissue resident memory CD4 T cells
研究口服疫苗特异性组织驻留记忆 CD4 T 细胞的组织定位和保护功能
  • 批准号:
    10646930
  • 财政年份:
    2023
  • 资助金额:
    $ 23.82万
  • 项目类别:
Identifying the mechanism of anti-colorectal immunity induced by mucoinvasive colonic bacteria
确定粘膜侵袭性结肠细菌诱导的抗结直肠免疫机制
  • 批准号:
    10585344
  • 财政年份:
    2022
  • 资助金额:
    $ 23.82万
  • 项目类别:
Chylomicron-responsive Tregs in EED
EED 中的乳糜微粒反应性 Tregs
  • 批准号:
    10641006
  • 财政年份:
    2022
  • 资助金额:
    $ 23.82万
  • 项目类别:
Mechanisms of maternal Immunoglobulin A control over the neonatal microbiota and the development of Necrotizing Enterocolitis.
母体免疫球蛋白 A 控制新生儿微生物群和坏死性小肠结肠炎发展的机制。
  • 批准号:
    10312104
  • 财政年份:
    2020
  • 资助金额:
    $ 23.82万
  • 项目类别:
Mechanisms of maternal Immunoglobulin A control over the neonatal microbiota and the development of Necrotizing Enterocolitis.
母体免疫球蛋白 A 控制新生儿微生物群和坏死性小肠结肠炎发展的机制。
  • 批准号:
    9883292
  • 财政年份:
    2020
  • 资助金额:
    $ 23.82万
  • 项目类别:
Mechanisms of maternal Immunoglobulin A control over the neonatal microbiota and the development of Necrotizing Enterocolitis.
母体免疫球蛋白 A 控制新生儿微生物群和坏死性小肠结肠炎发展的机制。
  • 批准号:
    10541105
  • 财政年份:
    2020
  • 资助金额:
    $ 23.82万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 23.82万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 23.82万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 23.82万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 23.82万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 23.82万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 23.82万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 23.82万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 23.82万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 23.82万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 23.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了